Babak Kazemi Nia

Babak Kazemi Nia practices at First Medical Associates in Germantown, Maryland.

Babak Kazemi Nia's NPI, 1659784205, was assigned on June 10, 2014. Babak Kazemi Nia holds Maryland license D82979.

Babak Kazemi Nia's primary practice is First Medical Associates, at 12800 Middlebrook Rd, Germantown, MD 20874 in Montgomery County. The practice phone is (240) 215-3301.

Babak Kazemi Nia's primary practice is First Medical Associates in Germantown, Maryland. The medical group on file is Maryland Internal Medicine. Dmand AI also links Babak Kazemi Nia to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Babak Kazemi Nia practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Babak Kazemi Nia's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Babak Kazemi Nia is licensed in Maryland.

CMS data shows 277 Medicare services from Babak Kazemi Nia across 7 procedure codes in 2024, for 79 Medicare patients. Medicare paid $21,107 for them. Every service was in an office.

CMS counts 79 Medicare patients who saw Babak Kazemi Nia in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Babak Kazemi Nia's median patient age at 61, with 39% women.

In 2024, Babak Kazemi Nia wrote 1,302 Medicare Part D claims for 271 patients. 93% of them were for generic drugs. CMS names the drug for 878 of them, across 25 drugs with 11 or more claims each, at $26,186 in total drug cost. In 2023, CMS named 721 claims across 24 drugs.

Babak Kazemi Nia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Babak Kazemi Nia as offering telehealth.

CMS Open Payments shows 249 general payments to Babak Kazemi Nia from 38 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $637.